BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 14, 2016
View Archived Issues
Sapience completes series A financing
Read More
Inotek initiates phase II trial of trabodenoson/latanoprost FDC in glaucoma
Read More
Redx Pharma discovers novel bacterial topoisomerase inhibitors
Read More
Vaccine Technologies HIV vaccine LFn-p24B/C displays immunogenicity in phase I study
Read More
Redhill Biopharma signs collaboration agreement with NIAID
Read More
Faes Farma patents H1 receptor antagonists
Read More
Bioaffinity Technologies renews collaboration with University of Texas
Read More
Bristol-Myers Squibb discloses RIP-3 inhibitors
Read More
Muses Labs partners with Metabolon to apply metabolomics to Alzheimer's disease
Read More
Daiichi Sankyo develops retinoid RORgamma t antagonists and IL-17 production inhibitors
Read More
Boehringer Ingelheim and Eli Lilly collaborate on phase Ib trial for BI-836845
Read More
CytRx announces initial phase III results for aldoxorubicin in soft tissue sarcoma
Read More
Mologen enrolls first patient in phase I study for lefitolimod with ipilimumab
Read More
Novel macrolides show promise against macrolide-resistant Gram-positive isolates
Read More
FDA grants priority review to NDA for chewable tablet presentation of mebendazole
Read More
Scynexis sells cyclophilin inhibition assets to Cypralis
Read More
Invasive lobular breast carcinoma model created using CRISPR/Cas9 somatic gene editing
Read More
Avacta and Glythera collaborate to develop targeted biotherapeutics as alternative to ADCs
Read More
FDA grants breakthrough therapy designation to LOXO-101
Read More
MRIGlobal receives DTRA contract award to support development of tularemia vaccine
Read More
TARIS Biomedical starts phase Ib trial for TAR-200
Read More
Alere's rapid point-of-care fourth-generation HIV test receives WHO prequalification
Read More
Amgen and Daiichi Sankyo sign Japanese biosimilar commercialization agreement
Read More
Urolithin A improves muscle function; Amazentis conducts clinical trial
Read More
Evelo and Epiva merge to create immuno-microbiome company
Read More